Cancer Prevention Research : Impact Factor & More
eISSN: 1940-6215pISSN: 1940-6207
Share this on:
Key Metrics
CiteScore 
4.9
H-Index
106
Impact Factor
< 5
SJR
Q1Oncology
SNIP
0.92
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Prevention Research
Cancer Prevention Research Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | AMER ASSOC CANCER RESEARCH |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Prevention Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Prevention Research
Sex-Based Differences in Circulating microRNA and Metabolite Signatures Associated with Physical Activity in Lynch Syndrome Carriers.
- 1 Jul 2026
- Cancer prevention research (Philadelphia, Pa.)
Advancing Gastric Cancer Chemoprevention: Early Signals and Ongoing Challenges.
- 1 Jul 2026
- Cancer prevention research (Philadelphia, Pa.)
Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis.
- 1 Jul 2026
- Cancer prevention research (Philadelphia, Pa.)
Will they use it? Patient and provider acceptance of chatbot screening and counseling for hereditary cancer syndromes in a geographically underserved population.
- 25 Jun 2026
- Cancer prevention research (Philadelphia, Pa.)
The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.
- 24 Jun 2026
- Cancer prevention research (Philadelphia, Pa.)
Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 Levels.
- 17 Jun 2026
- Cancer prevention research (Philadelphia, Pa.)
Sex-Based Differences in Circulating microRNA and Metabolite Signatures Associated with Physical Activity in Lynch Syndrome Carriers.
- 1 Jul 2026
- Cancer prevention research (Philadelphia, Pa.)
Advancing Gastric Cancer Chemoprevention: Early Signals and Ongoing Challenges.
- 1 Jul 2026
- Cancer prevention research (Philadelphia, Pa.)
Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis.
- 1 Jul 2026
- Cancer prevention research (Philadelphia, Pa.)
Will they use it? Patient and provider acceptance of chatbot screening and counseling for hereditary cancer syndromes in a geographically underserved population.
- 25 Jun 2026
- Cancer prevention research (Philadelphia, Pa.)
The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.
- 24 Jun 2026
- Cancer prevention research (Philadelphia, Pa.)
Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 Levels.
- 17 Jun 2026
- Cancer prevention research (Philadelphia, Pa.)
FAQs on Cancer Prevention Research
How long has Cancer Prevention Research been actively publishing? 
What is the publishing frequency of Cancer Prevention Research?
How many articles did Cancer Prevention Research publish last year?
What is the eISSN & pISSN for Cancer Prevention Research?
What is Citescore for Cancer Prevention Research?
What is the H Index for Cancer Prevention Research ?
What is SNIP score for Cancer Prevention Research?
What is the SJR for Cancer Prevention Research?
Who is the publisher of Cancer Prevention Research?
